Search

Search Constraints

You searched for: Author/Creator Rivero, M

Search Results

31. P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. (25th January 2019)

32. P439 Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry. (25th January 2019)

33. P476 Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry. (27th May 2021)

34. P505 Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry. (25th January 2019)

35. P541 Diagnosis, management, and evolution of acute pancreatitis secondary to thiopurines in patients with Inflammatory Bowel Disease: an ENEIDA registry study. (30th January 2023)

36. P545 Safety of ustekinumab in pregnant patients with inflammatory bowel disease and in their offspring: results from the DUMBO registry of GETECCU. (21st January 2022)

37. P550 Management of immunomodulators and biologic agents in pregnant patients with inflammatory bowel: results from the DUMBO registry of GETECCU. (21st January 2022)

38. P625 Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis. (30th January 2023)

39. P630 Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry). (27th May 2021)

40. P631 Treatment of established post-operative recurrence of Crohn's disease with anti-TNF agents: Preliminary data of a multicentre, nationwide study. (16th January 2018)